Van Selm et al. highlight the considerable lack of data regarding migrants who use drugs and their access to drug dependency services, with 15 recommendations designed to improve data collection and service accessibility and availability,
The EMCDDA shed light on emerging trends, challenges, and policy implications surrounding drug use in Europe up until the end of 2022, revealing high availability of substances and a greater need for harm reduction services.
Czechia's plans to legally regulate cannabis are likely to be challenged by other EU member states who oppose the move, despite the ongoing harms and costs of prohibition across Europe.
EHRA publish their latest edition of CHECK magazine, focusing on the disproportionate levels of stigmatisation and discrimination that women who use drugs face as a result of existing gender inequalities and prohibitionist policies.
The escalating HIV crisis in Eastern Europe and Central Asia highlights the urgent need for harm reduction interventions to mitigate the spread of infection and protect people pushed into vulnerability.
Sypsa et al. highlight the efficacy of peer-driven programmes to early identify a localised HIV outbreak and to implement health responses to mitigate it.
Safer consumption rooms led to reduced public injection, fewer health risks and lower crime, raising further questions about why they are not more widespread.
